Welcome to our dedicated page for CONCENTRA GROUP HOLDINGS PAREN SEC filings (Ticker: CON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Concentra Group Holdings Parent, Inc. (NYSE: CON) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a U.S. public issuer in the healthcare and occupational health services sector. Concentra files current reports on Form 8-K to communicate material events, including quarterly financial results, dividend declarations, share repurchase authorizations, and governance changes such as director appointments and executive equity awards.
Recent Form 8-K filings describe the company’s financial results for quarters ended June 30 and September 30, 2025, with accompanying press releases and presentations furnished as exhibits. These materials outline revenue performance, income from operations, patient visit metrics, and the expansion of Concentra’s network of occupational health centers and onsite health clinics. Other 8-K filings detail cash dividend declarations and the authorization of a share repurchase program, providing insight into the company’s capital allocation decisions.
Additional filings report governance-related events. For example, Concentra has filed 8-Ks regarding the appointment of new members to its Board of Directors and the grant of restricted stock to named executive officers under its equity incentive plan. These disclosures help investors understand changes in the company’s leadership and executive compensation structure. The company has also filed 8-Ks related to preliminary operational metrics and presentations at investor conferences.
Through Stock Titan, users can review these SEC filings alongside AI-powered summaries that explain key points from documents such as Form 8-K and related exhibits. Real-time updates from the EDGAR system help ensure that new filings for CON are reflected promptly, while AI-generated highlights can assist in identifying important information about financial performance, dividends, share repurchases, and governance matters without reading every line of each filing.
Concentra Group Holdings Parent, Inc. reported a Form 4 showing an officer received a grant of 60,000 shares of common stock on November 4, 2025 at $0, increasing beneficial ownership to 120,000 shares, held directly. The award is restricted stock that vests in equal annual installments over four years. The officer’s title is Executive Vice President, Chief Clinical Services Officer.
Concentra Group Holdings Parent, Inc. (CON) disclosed a Form 4 showing a director acquired 7,748 shares of common stock as a restricted stock grant on November 4, 2025.
The restricted stock will vest in full on November 4, 2026, subject to certain exceptions. Following the transaction, the reporting person beneficially owns 74,000 shares directly. The grant was reported at a price of $0 per share.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. The company’s Chief Executive Officer and Director acquired 225,000 shares of common stock on 11/04/2025 via a grant coded “A”. The filing lists a $0 price, consistent with a restricted stock award.
The award is described as restricted stock that will vest in equal annual installments over four years. Following this transaction, the reporting person beneficially owned 482,831 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award. Executive Vice President & Chief Legal Counsel Timothy F. Ryan acquired 60,000 shares of common stock on 11/04/2025 as a restricted stock grant at $0.
The award will vest in equal annual installments over four years. Following the grant, Ryan beneficially owned 120,000 shares, held directly.
Concentra Group Holdings Parent (CON) reported a director equity award on a Form 4. On November 4, 2025, the director received two grants of common stock: 7,748 shares that vest in equal annual installments over five years, and 7,748 shares that vest in full on November 4, 2026, subject to certain exceptions. The reported transaction price was $0, reflecting restricted stock awards. Following these grants, the director beneficially owns 15,496 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity grant. On November 4, 2025, an officer acquired 60,000 shares of common stock as a restricted stock award at $0, scheduled to vest in equal annual installments over four years.
After this grant, the reporting person beneficially owns 120,000 shares, held directly. The officer’s title is Executive Vice President, Chief Operating Officer - West.
Concentra Group Holdings Parent, Inc. reported an insider equity award to a director.
On 11/04/2025, 7,748 shares of common stock were acquired at $0 (Transaction Code A). Per the footnote, this was a grant of restricted stock that will vest in full on November 4, 2026.
Following the grant, 5,533,794 shares were beneficially owned directly. Indirect holdings include 1,023,455 shares by The Rocco A. Ortenzio Separate Descendants Trust FBO Robert Ortenzio and 1,032,115 shares by the Robert A. Ortenzio Descendants Trust.
Concentra Group Holdings Parent, Inc. (CON) reported an insider equity award on a Form 4. The company’s Executive Vice President, Chief Marketing and Innovation Officer received 60,000 shares of common stock on 11/04/2025 via a restricted stock grant at $0 per share.
The restricted stock will vest in equal annual installments over four years. After this grant, the reporting person beneficially owns 120,000 shares, held directly.
Concentra Group Holdings Parent, Inc. disclosed a Form 4 for its Senior Vice President, Human Resources, showing an award of 40,000 shares of common stock on 11/04/2025. The award is restricted stock that will vest in equal annual installments over four years at a price of $0.
After this grant, the reporting person beneficially owns 80,000 shares, held directly.
Concentra Group Holdings Parent, Inc. (CON) insider transaction: On 11/04/2025, the Executive Vice President and Chief Accounting Officer received a grant of 60,000 shares of common stock at $0 as restricted stock. The award will vest in equal annual installments over four years.
Following this grant, the officer beneficially owns 120,000 shares, held directly.
FAQ
What is the current stock price of CONCENTRA GROUP HOLDINGS PAREN (CON)?
What is the market cap of CONCENTRA GROUP HOLDINGS PAREN (CON)?
